Post

New research · Ophthalmology
Ocular immunology and inflammation · 2d
Cohort studyOcular immunology and inflammation · 2026

Risk of Cataract and Ocular Hypertension in Chronic Anterior Uveitis Patients on Stable-Dosing of Topical Corticosteroids.

Nicholas J Butler, Maxwell Pistilli, Kurt A Dreger … SITE Cohort Study Research Group
Read paper
OphthalmologyCohort study

Using one or fewer steroid eye drops daily was not linked to excess cataract risk.

Risk of Cataract and Ocular Hypertension in Chronic Anterior Uveitis Patients on Stable-Dosing of Topical Corticosteroids.

Nicholas J Butler … SITE Cohort Study Research Group
Ocular immunology and inflammation · 2026
Purpose

To assess the association of cataract progression and intraocular pressure (IOP) elevation with stable-dosing of topical corticosteroid for chronic anterior uveitis (chronic anterior uveitis).

Methods

All patients with chronic anterior uveitis from the Systemic Immunosuppressive Therapy for Eye Diseases Cohort treated with topical prednisolone 1% or equipotent equivalent for at least six months were analyzed.

n = 346 patients
Results

eyes at this lower dose showed no higher rate of new cataracts

aHR 0.91 (95% CI 0.29 to 2.84)
null = 10.292.84
CI crosses the null - not significant
More results

For the incident cataract outcome, 346 patients met the eligibility criteria.

Similarly, higher daily topical corticosteroid exposure conferred greater risk of both IOP outcomes, though plateau effects were observed.

More results

For eyes receiving ≤1 drop daily of prednisolone 1% or equivalent, there was no excess risk of either IOP outcome [aHR for ≥21 mmHg, 0.77 (95% CI, 0.19, 3.05) and aHR for ≥30 mmHg, 0.92 (95% CI, 0.11, 7.76)].

“
Conclusion

Stable-dosing of topical prednisolone 1% or equivalent more than once daily was associated with increased cataract formation and IOP elevation over medium-term follow-up, whereas ≤1 drop/day was not.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cross-sectional
44.1%
had too much homocysteine in the blood, a far larger share than in dry AMD or healthy eyes
Cohort Study
92.3%
most laser-treated eyes had a favorable eye-structure outcome
Cohort Study
56%
lost three or more lines on the eye-chart vision test
Cohort Study
50%
older patients were more likely to lose three or more lines of vision
Study
81%
trials where mask air leaks were detected blowing toward the eyes
Cohort Study
13.5%
Central retinal artery peak blood-flow speed was 13.5% lower in diabetic patients.
Study
379 +/- 156 microm
lower thickness in the central retina, checked with an eye scan
Case Report
9 of 10 eyes
eyes had better measured vision after treatment